Loading
AK Medical Holdings Ltd. Stock: price and insider trades · Hong Kong
1 insider bought shares over the last 90 days, the latest by Zhao Xiaohong, filed 05 Aug 2026.
AK Medical Holdings Ltd.: what insiders have been doing
This page follows insider dealings at AK Medical Holdings Ltd. as filed with HKEX, a company from the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 8 filings came from 2 insiders.
Purchases and sales both appear in the filings: 3 purchases (1 insider, €114k) and 3 sales (1 insider). No amount is published for 5 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive. Biggest ticket of the year: €114k, bought by Zhao Xiaohong and made public on 3 July 2026 (0.020% of market cap).
Compared with its exchange (736 companies, median 5 filings), a count of 8 filings is above the norm. Looking back to 2026, when coverage begins, insiders filed 3 purchases and 3 sales.
The last insider purchase was made public on 5 August 2026, 74 days ago. The median gap between a trade and its publication by HKEX is 5 days. This delay matters because a trade only becomes useful information once it is public.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€113,976
3 ops. · all time
Sell Volume
n/a
3 ops. · all time
Who traded when
BuySaleZhao Xiaohong3 buys3 sales
Since the insiders bought
- -15.6%Entry HK$5.53 · Close at T+90 HK$4.67
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,920 of 23,473 companies
75.5
score / 100
Value68
Quality83
FCF yld5.7%
Earn yld7.1%
EV/EBITDA9.6x
ROE14%
Gross mgn61%
Net mgn23%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$4.52
Analyst consensus
5 analysts1.00/5
HK$7.03Target HK$7.84(+74%)HK$8.46
Income statement
RevenueHK$1.5B
Gross profitHK$897.4M61% margin
EBITDAHK$504.8M34% margin
Net incomeHK$339.1M24.2% margin
Valuation
PER (trailing)11.9x
PER (forward)10.8x
P/Book1.5x
Beta-0.24
Balance sheet & cash
Market capHK$4.8B
Total debtHK$86.4M
Free Cash FlowHK$272M
Debt / Equity0%
Profitability & ownership
ROE13.7%
ROA7.5%
% insiders53.6%
% institutions14.9%
Last declaration on 5 August 2026
Declarations8 total
103,000 sharesShareXHKGHKEX:DA20260805E00345
Canonical exit: 21 Oct 2026 (T+90)
79,000 sharesShareXHKGHKEX:DA20260805E00344
Canonical exit: 21 Oct 2026 (T+90)
26,000,000 sharesShareXHKGHKEX:DA20260703E00052
200,000 shares@ HK$5.10290.020% mcap100.0% of flowShareXHKGHKEX:DA20260703E00051
Canonical exit: 28 Sept 2026 (T+90)
62,524 sharesShareXHKGHKEX:DA20260415E00599
6,947 sharesShareXHKGHKEX:DA20260415E00598
8,335 sharesShareXHKGHKEX:DA20260415E00597
39,421 sharesShareXHKGHKEX:DA20260402E00004
8 of 8 declarations
About AK Medical Holdings Ltd.
AK Medical Holdings Ltd. is a company specializing in the manufacturing of medical devices, particularly orthopedic implants. It is listed on the Hong Kong Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
